23.45
-0.21 (-0.89%)
| Previous Close | 23.66 |
| Open | 23.42 |
| Volume | 877,133 |
| Avg. Volume (3M) | 824,511 |
| Market Cap | 1,404,994,432 |
| Price / Earnings (Forward) | 384.62 |
| Price / Sales | 2.98 |
| Price / Book | 4.59 |
| 52 Weeks Range | |
| Earnings Date | 4 Sep 2025 |
| Profit Margin | -9.83% |
| Operating Margin (TTM) | -46.68% |
| Diluted EPS (TTM) | -0.740 |
| Quarterly Revenue Growth (YOY) | 45.70% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 1.95 |
| Operating Cash Flow (TTM) | 47.95 M |
| Levered Free Cash Flow (TTM) | 35.26 M |
| Return on Assets (TTM) | -5.98% |
| Return on Equity (TTM) | -15.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | Phreesia, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.5 |
| Average | -0.50 |
|
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 4.32% |
| % Held by Institutions | 95.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Granahan Investment Management, Llc | 30 Jun 2025 | 1,302,785 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 38.00 (Canaccord Genuity, 62.05%) | Buy |
| Median | 34.00 (44.99%) | |
| Low | 32.00 (Keybanc, 36.46%) | Buy |
| 32.00 (Stephens & Co., 36.46%) | Buy | |
| Average | 34.44 (46.87%) | |
| Total | 9 Buy | |
| Avg. Price @ Call | 27.97 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Keybanc | 08 Oct 2025 | 32.00 (36.46%) | Buy | 23.25 |
| 14 Jul 2025 | 35.00 (49.25%) | Buy | 27.60 | |
| JMP Securities | 08 Sep 2025 | 34.00 (44.99%) | Buy | 26.78 |
| Truist Securities | 08 Sep 2025 | 36.00 (53.52%) | Buy | 26.78 |
| Canaccord Genuity | 05 Sep 2025 | 38.00 (62.05%) | Buy | 28.13 |
| DA Davidson | 05 Sep 2025 | 33.00 (40.72%) | Buy | 28.13 |
| Needham | 05 Sep 2025 | 35.00 (49.25%) | Buy | 28.13 |
| Piper Sandler | 05 Sep 2025 | 34.00 (44.99%) | Buy | 28.13 |
| Stephens & Co. | 03 Sep 2025 | 32.00 (36.46%) | Buy | 30.44 |
| Mizuho | 27 Aug 2025 | 36.00 (53.52%) | Buy | 31.99 |
No data within this time range.
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 May 2013 | 07 Feb 2013 | 17 Jun 2013 | 0.5625 Cash |
| 27 Feb 2013 | 06 Feb 2013 | 15 Mar 2013 | 0.5625 Cash |
| 28 Nov 2012 | - | 15 Dec 2012 | 0.5625 Cash |
| 29 Aug 2012 | - | 15 Sep 2012 | 0.5625 Cash |
| 30 May 2012 | - | 15 Jun 2012 | 0.5625 Cash |
| 28 Feb 2012 | - | 15 Mar 2012 | 0.5625 Cash |
| 30 Aug 2011 | - | 15 Sep 2011 | 0.5625 Cash |
| 27 May 2011 | - | 15 Jun 2011 | 0.5625 Cash |
| 25 Feb 2011 | - | 15 Mar 2011 | 0.5625 Cash |
| 29 Nov 2010 | - | 15 Dec 2010 | 0.5625 Cash |
| 30 Aug 2010 | - | 15 Sep 2010 | 0.5625 Cash |
| 27 May 2010 | - | 15 Jun 2010 | 0.5625 Cash |
| 25 Feb 2010 | - | 15 Mar 2010 | 0.5625 Cash |
| 27 Nov 2009 | - | 15 Dec 2009 | 0.5625 Cash |
| 28 Aug 2009 | - | 15 Sep 2009 | 0.5625 Cash |
| 28 May 2009 | - | 15 Jun 2009 | 0.5625 Cash |
| 25 Feb 2009 | - | 16 Mar 2009 | 0.5625 Cash |
| 26 Nov 2008 | - | 15 Dec 2008 | 0.5625 Cash |
| 27 Aug 2008 | - | 15 Sep 2008 | 0.46875 Cash |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |